Industry leader Michael Cunningham

National Head of Life Sciences

michael.cunningham@au.gt.com

The rapidly evolving health care landscape presents many opportunities – and risks – for biotechnology, pharmaceutical and medical technology companies.

Challenges such as drug counterfeiters, supply-chain failures, new government regulations and investors looking for a quick return, are forcing companies in this sector to constantly transform their business and business processes.

With our local knowledge and international reach, Grant Thornton can advise you at every stage of their development. The mid-market is our specialty.